Compare Edwards Lifesciences Corporation Common Stock (EW) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Nasdaq Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Nasdaq Inc trades at $92.37 (market cap $51.39B). The key difference: Edwards Lifesciences Corporation Common Stock and Nasdaq Inc are close in size by market cap, and Nasdaq Inc pays a 1.26% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | NDAQ | |
|---|---|---|
Market Cap | $49.44B | $51.39B |
Volume | 3,508,027 | 3,123,797 |
Sector | Health | Financials |
52-Week High | $95.18 | $100.98 |
52-Week Low | $72.65 | $76.85 |
Enterprise Value | $45.90B | $57.84B |
Typical Hold Time | — | 125 Days |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nasdaq (NDAQ) trades at $92.37, up 0.11% with a bearish technical signal despite beating earnings estimates for three consecutive quarters. The company shows strong fundamentals with 2025 revenue of $8.26B, net income margin of 22.52%, and consistent profitability. Recent news highlights Nasdaq's AI-powered Calypso platform expansion and index composition changes, while analyst consensus remains bullish with a $110.71 price target representing 20% upside potential.
NDAQ presents a compelling investment case with strong financial performance and analyst support, though technical indicators suggest near-term caution. The stock offers growth potential through technology innovation and market leadership, balanced by market volatility risks and competitive pressures in financial technology. Current valuation metrics (P/E 26.8, P/S 6.04) reflect premium pricing relative to historical averages.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
